Non insulin-dependent diabetes mellitus (NIDDM) is a genetic disorder
with an epidemic development in the westernized civilisations. The kno
wledge of genetic factors would help in screening those individuals su
sceptible to develop diabetes, to prevent overfeeding, overweight and
sedentarity ; these environmental factors can reveal or worsen diabete
s. NIDDM is a clinically and genetically heterogeneous disorder, proba
bly due to the alteration of several genes. The collection of numerous
and large families with several diabetic subjects and the sorting in
clinically homogeneous subgroups are necessary to identify the suscept
ibility genes. It has been recently shown that glucokinase (enzyme tha
t phosphorylates glucose in pancreatic beta-cell and liver) was the ca
use of MODY (maturity onset diabetes of the young), a NIDDM subtype ch
aracterized by an autosomic dominant mode of inheritance and an early
age of onset. Glucokinase mutations are responsible for a mild hypergl
ycemia with onset during childhood or during pregnancy; in addition, d
iabetes can be due to mutations in mitochondrial DNA in families where
the disease is maternally transmitted and often associated with heari
ng loss. These two genetic defects can account for about 2 % to 5 % of
NIDDM patients each. Screening for these mutations is feasible.